Treatment | Moderate exacerbations (%) (n = 101) | Severe exacerbations (%) (n = 118) | P-value |
---|---|---|---|
Short-acting ß2 agonist | 94 (93%) | 109 (92%) | 0.84 |
ß2 agonist by subcutaneous injection | 6 (6%) | 18 (15%) | 0.03 |
Systemic corticosteroids | 62 (61%) | 94 (80%) | 0.003 |
Antibiotics | 60 (59%) | 81 (69%) | 0.15 |
Hospital referral | 2 (2%) | 8 (7%) | 0.11 |